Log in or Sign up for Free to view tailored content for your specialty!
Pulmonary Vascular Disease News
Catheter-directed fibrinolysis safe in intermediate-high-risk pulmonary embolism
In adults with intermediate-high-risk pulmonary embolism, catheter-directed fibrinolysis plus anticoagulation appears safe and was associated with favorable imaging-based findings compared with anticoagulation monotherapy, data show.
Macitentan demonstrates safety in real-world patients with pulmonary arterial hypertension
Macitentan showed no new safety signals in patients with pulmonary arterial hypertension from two real-world datasets, according to a study published in Pulmonary Circulation.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Speaker discusses ‘nuanced’ guidance on VTE management
NASHVILLE, Tenn. — In this Healio exclusive, Samantha Pettigrew, MD, discusses CHEST’s 2021 update to its clinical guidelines on using anticoagulation for venous thromboembolism at the CHEST Annual Meeting.
E-cigarettes confer endothelial dysfunction similar to traditional cigarettes
Reduced flow-mediated dilation was observed among both e-cigarette and traditional cigarette users, but circulating levels of certain inflammatory and thrombotic mediators differed between the two groups, researchers reported.
VIDEO: Takeaways from CHEST 2022 with Parth Rali, MD
NASHVILLE, Tenn. — In this Healio exclusive, Parth Rali, MD, spotlights education on mechanical circulatory support devices at the CHEST Annual Meeting.
Patients with scleroderma should receive regular pulmonary arterial hypertension screening
SAN DIEGO — Pulmonary arterial hypertension’s prevalence and rate of progression in patients with connective tissue diseases should make regular screening a priority, according to a speaker at the Congress of Clinical Rheumatology West.
VIDEO: Takeaways from CHEST 2022 with Belinda Natalia Rivera-Lebron, MD, MS
NASHVILLE, Tenn. — In this Healio exclusive, Belinda Natalia Rivera-Lebron, MD, MS, highlights the role of artificial intelligence as a tool for acute pulmonary embolism risk stratification.
Patients with pulmonary hypertension at high risk for acute kidney injury
NASHVILLE, Tenn. — Patients admitted with background secondary pulmonary hypertension may have an increased risk for acute kidney injury and adverse outcomes, according to a presenter at the CHEST Annual Meeting.
Patients with IPF who experience in-hospital cardiac arrest face increased mortality rate
NASHVILLE, Tenn. — Idiopathic pulmonary fibrosis appeared associated with increased mortality rates and worse outcomes among in-hospital cardiac arrest survivors, according to study results presented at the CHEST Annual Meeting.
Nintedanib maintains safety, efficacy long-term in patients with SSc-associated ILD
Nintedanib maintains its safety and efficacy for up to 3 years in patients with systemic sclerosis-associated interstitial lung disease, according to data published the Annals of the Rheumatic Diseases.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read